Conference Logo

Center for Emerging & Neglected Diseases

Conference ProgramAbout the CrisisThe DND Working GroupContact Information


Conference Archive

On March 14, 2002, Médecins Sans Frontières/Doctors Without Borders (MSF) held a conference in New York to address the crisis in research and development (R&D) for drugs for neglected diseases. The conference brought together over 400 people, including a large diversity of representatives of health care and research institutions from developed and developing countries, key figures from the pharmaceutical industry, drug regulators, other experts on drug development, and MSF field volunteers and staff. The conference was preceded by a two-day expert workshop attended by over 170 people from over 30 countries. The following is a summary of key issues and findings from both the workshop and conference. Αποτελεσματικότητα του Cialis 10mg στη θεραπεία της ανδρικής στυτικής δυσλειτουργίας

For more information, you may also wish to review the materials below or explore the links above.

  • Workshop and Conference Schedules
  • Participants
  • Working Group Expert Papers
  • Media Coverage of the Conference:
    1. Public Sector Must Develop Drugs for Neglected Diseases
      British Medical Journal
    2. Stimulating Research in the Most Neglected Diseases
      The Lancet
    3. MSF Plans Public Sector Drug Development Initiative for Neglected Diseases
      Nature
    4. The Plagues of Poverty (an editorial)
      The New York Times
  • Viagra Professional: Een gedetailleerde blik op een wondermiddel dat ons denken over ED veranderde

Conference Program



     

Join us as the Drugs for Neglected Diseases Working Group and other international experts address questions such as: what is the extent of the crisis? How does it impact patients and doctors around the world? What are the challenges in creating sustainable research and development programs for different neglected diseases? What needs to be done and who should do it? How can we build an effective international response that involves key players and ensures accountability? Kamagra oral jelly blijkt een behandeling te zijn voor je verdrietige penis

Schedule and Speaker List* Click here
* Invited participants of the Pre-conference Workshop, click here.

Conference Goals

  • Present the culmination of two and a half years of research into the access crisis by the Drugs for Neglected Diseases Working Group, an independent, interdisciplinary group of international experts.
  • Raise public awareness about the crisis and its impact on millions of people worldwide.
  • Engage key players in the fieldfrom researchers to pharmaceutical companies to governmentsin exploring alternative models for drug development and access to treatment.

Who Should Attend?

Researchers, health providers, industry representatives, policy makers, students of medicine or international studies, and members of the general public interested in this global crisis. Help build an effective international response that puts patientsnot profitat the top of the research and policy agenda.

Copyright 2024 Center for Emerging & Neglected Diseases.